Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Delgado

Showing results (611-620 of 680) with videos related to

Pageof 68
Sort By:
Molecular Metabolism|November 1, 2019
miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver diseasePablo Fernández-Tussy, David Fernández-Ramos, Fernando Lopitz-Otsoa, et al.
International Journal of Molecular Sciences|December 2, 2020
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl<sub>4</sub>-Induced Liver FibrosisMaria Mercado-Gómez, Fernando Lopitz-Otsoa, Mikel Azkargorta, et al.
Cancers|January 11, 2022
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized TherapyFeifei Guo, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, et al.
Cell Death & Disease|September 22, 2018
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosisDavid Fernández-Ramos, Pablo Fernández-Tussy, Fernando Lopitz-Otsoa, et al.
JHEP Reports : Innovation in Hepatology|May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injuryPaula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Hepatology Communications|November 22, 2017
Role of Aramchol in steatohepatitis and fibrosis in miceMarta Iruarrizaga-Lejarreta, Marta Varela-Rey, David Fernández-Ramos, et al.
Nature Communications|December 14, 2017
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injuryLucía Barbier-Torres, Paula Iruzubieta, David Fernández-Ramos, et al.
Nature Communications|March 2, 2022
Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosisDiego Sáenz de Urturi, Xabier Buqué, Begoña Porteiro, et al.
Cell Metabolism|February 22, 2020
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride AssemblyJorge Simon, Maitane Nuñez-García, Pablo Fernández-Tussy, et al.
Hepatology (Baltimore, Md.)|November 14, 2025
NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathwayL Estefanía Zapata-Pavas, Marina Serrano-Macia, Miguel Ángel Merlos Rodrigo, et al.
Pageof 68

Showing results (611-620 of 680) with videos related to

Sort By:
Pageof 68
Molecular Metabolism|November 1, 2019
miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver diseasePablo Fernández-Tussy, David Fernández-Ramos, Fernando Lopitz-Otsoa, et al.
International Journal of Molecular Sciences|December 2, 2020
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl<sub>4</sub>-Induced Liver FibrosisMaria Mercado-Gómez, Fernando Lopitz-Otsoa, Mikel Azkargorta, et al.
Cancers|January 11, 2022
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized TherapyFeifei Guo, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, et al.
Cell Death & Disease|September 22, 2018
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosisDavid Fernández-Ramos, Pablo Fernández-Tussy, Fernando Lopitz-Otsoa, et al.
JHEP Reports : Innovation in Hepatology|May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injuryPaula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Hepatology Communications|November 22, 2017
Role of Aramchol in steatohepatitis and fibrosis in miceMarta Iruarrizaga-Lejarreta, Marta Varela-Rey, David Fernández-Ramos, et al.
Nature Communications|December 14, 2017
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injuryLucía Barbier-Torres, Paula Iruzubieta, David Fernández-Ramos, et al.
Nature Communications|March 2, 2022
Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosisDiego Sáenz de Urturi, Xabier Buqué, Begoña Porteiro, et al.
Cell Metabolism|February 22, 2020
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride AssemblyJorge Simon, Maitane Nuñez-García, Pablo Fernández-Tussy, et al.
Hepatology (Baltimore, Md.)|November 14, 2025
NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathwayL Estefanía Zapata-Pavas, Marina Serrano-Macia, Miguel Ángel Merlos Rodrigo, et al.
Pageof 68